Carlyle Group Inc.
Q2 2023 13F-HR Holdings
Net value change ($000)
-544,915
(-16.3%)
New positions
0
Sold out positions
4
Turnover %
3.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PHAT | 29,205 | 139.9% |
| GTM | 24,930 | 2.8% |
| VERA | 15,883 | 69.4% |
| OKUR | 5,442 | 44.5% |
| SMHI | 5,021 | 50.2% |
| SLNO | 2,559 | 100.9% |
| VRNA | 2,531 | 5.1% |
| EFFECTOR THERAPEUTICS INC | 2,266 | 134.2% |
| INVH | 1,514 | 10.2% |
| HilleVax, Inc. | 1,434 | 4.8% |
Top Reduces (Value $000, Stocks/ETFs)
| MKSI | -375,257 | -49.9% |
| QDEL | -77,627 | -7.0% |
| PCVX | -72,080 | -100.0% |
| Vitru Ltd | -42,039 | -29.6% |
| GDS | -31,237 | -41.1% |
| GETY | -11,901 | -19.6% |
| LIFE STORAGE, INC. | -11,274 | -100.0% |
| ACET | -7,044 | -57.9% |
| JSPR | -3,942 | -25.0% |
| CymaBay Therapeutics, Inc. | -1,144 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|